[{"address1": "500 West 5th Street", "address2": "Suite 1200", "city": "Austin", "state": "TX", "zip": "78701", "country": "United States", "phone": "512 900 4690", "website": "https://www.shattucklabs.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Shattuck Labs, Inc., a clinical-stage biotechnology company, develops therapeutics for the treatment of cancer and autoimmune disease in the United States. The company's lead product candidate is SL-172154, which is in Phase 1 clinical trial for the treatment of ovarian, fallopian tube, and peritoneal cancers. Shattuck Labs, Inc. was incorporated in 2016 and is headquartered in Austin, Texas.", "fullTimeEmployees": 75, "companyOfficers": [{"maxAge": 1, "name": "Dr. Taylor H. Schreiber M.D., Ph.D.", "age": 44, "title": "Co-Founder, CEO & Director", "yearBorn": 1980, "fiscalYear": 2023, "totalPay": 792885, "exercisedValue": 0, "unexercisedValue": 357187}, {"maxAge": 1, "name": "Mr. Andrew R. Neill M.B.A.", "age": 39, "title": "Chief Financial Officer", "yearBorn": 1985, "fiscalYear": 2023, "totalPay": 603956, "exercisedValue": 0, "unexercisedValue": 496087}, {"maxAge": 1, "name": "Dr. Arunthathy Nirmalini Pandite M.B.A., M.D.", "age": 65, "title": "Chief Medical Officer", "yearBorn": 1959, "fiscalYear": 2023, "totalPay": 695243, "exercisedValue": 0, "unexercisedValue": 434807}, {"maxAge": 1, "name": "Dr. Abhinav A. Shukla Ph.D.", "age": 51, "title": "Chief Technical Officer", "yearBorn": 1973, "fiscalYear": 2023, "totalPay": 567398, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Stephen  Stout J.D., Ph.D.", "age": 49, "title": "General Counsel, Corporate Secretary and Chief Ethics & Compliance Officer", "yearBorn": 1975, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Casi  DeYoung", "age": 53, "title": "Chief Business Officer", "yearBorn": 1971, "fiscalYear": 2023, "totalPay": 523482, "exercisedValue": 0, "unexercisedValue": 493071}, {"maxAge": 1, "name": "Dr. Thomas  Lampkin Pharm.D.", "title": "Senior Vice President of Regulatory Affairs", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. George  Fromm Ph.D.", "title": "Co-Chief Scientific Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Suresh de Silva Ph.D.", "title": "Co-Chief Scientific Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Kelli  Collin M.S.", "title": "Senior Vice President of Quality", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 5, "boardRisk": 6, "compensationRisk": 7, "shareHolderRightsRisk": 8, "overallRisk": 7, "governanceEpochDate": 1738368000, "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 4, "previousClose": 1.25, "open": 1.26, "dayLow": 1.24, "dayHigh": 1.36, "regularMarketPreviousClose": 1.25, "regularMarketOpen": 1.26, "regularMarketDayLow": 1.24, "regularMarketDayHigh": 1.36, "beta": 1.711, "forwardPE": -1.4122494, "volume": 127071, "regularMarketVolume": 127071, "averageVolume": 214361, "averageVolume10days": 111500, "averageDailyVolume10Day": 111500, "bid": 1.3, "ask": 1.36, "bidSize": 100, "askSize": 100, "marketCap": 63493804, "fiftyTwoWeekLow": 0.94, "fiftyTwoWeekHigh": 11.76, "priceToSalesTrailing12Months": 9.866947, "fiftyDayAverage": 1.1897, "twoHundredDayAverage": 3.382375, "currency": "USD", "enterpriseValue": -22949188, "floatShares": 26751900, "sharesOutstanding": 47739700, "sharesShort": 1933707, "sharesShortPriorMonth": 2039133, "sharesShortPreviousMonthDate": 1735603200, "dateShortInterest": 1738281600, "sharesPercentSharesOut": 0.0405, "heldPercentInsiders": 0.14303, "heldPercentInstitutions": 0.65405, "shortRatio": 15.08, "shortPercentOfFloat": 0.060900003, "impliedSharesOutstanding": 47739700, "bookValue": 2.023, "priceToBook": 0.6574395, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1727654400, "netIncomeToCommon": -74418000, "trailingEps": -1.53, "forwardEps": -1.07, "enterpriseToRevenue": -3.566, "enterpriseToEbitda": 0.303, "52WeekChange": -0.86368597, "SandP52WeekChange": 0.22903383, "exchange": "NMS", "quoteType": "EQUITY", "symbol": "STTK", "underlyingSymbol": "STTK", "shortName": "Shattuck Labs, Inc.", "longName": "Shattuck Labs, Inc.", "firstTradeDateEpochUtc": 1602250200, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EST", "uuid": "64a83d67-d0cd-3885-8206-d0f94edae33a", "messageBoardId": "finmb_378179277", "gmtOffSetMilliseconds": -18000000, "currentPrice": 1.33, "targetHighPrice": 1.2, "targetLowPrice": 1.2, "targetMeanPrice": 1.2, "targetMedianPrice": 1.2, "recommendationKey": "none", "numberOfAnalystOpinions": 1, "totalCash": 90058000, "totalCashPerShare": 1.886, "ebitda": -75707000, "totalDebt": 3615000, "quickRatio": 7.262, "currentRatio": 7.962, "totalRevenue": 6435000, "debtToEquity": 3.743, "revenuePerShare": 0.132, "returnOnAssets": -0.41074002, "returnOnEquity": -0.71091, "grossProfits": -60308000, "freeCashflow": -35133624, "operatingCashflow": -62564000, "revenueGrowth": 3.369, "operatingMargins": -5.9793105, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2025-02-15"}]